Request Deal Involvement
Bristol Myers Squibb completed the acquisition of Turning Point Therapeutics for $4.1bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Goldman Sachs
legal advisors
Cooley
legal advisors to financial advisors
Skadden Arps Slate Meagher & Flom
financial advisors
Gordon Dyal & Co
legal advisors
Kirkland & Ellis
pr advisors
Joele Frank
legal advisors to financial advisors
Simpson Thacher & Bartlett
or
Principals
target
TURNING POINT THERAPEUTICS
bidder
BRISTOL MYERS SQUIBB COMPANY
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite